The goal of this observational study is to investigate whether daily physical activities measured with a smartphone are related to the possible side effects or other physical complaints that arise as a result of cancer treatment. The investigators want to test whether the number of steps per day, both before and during treatment, are related to possible side effects or other physical complaints of the treatment using a smartphone. Knowledge about this relationship gives us possible starting points to prevent and/or reduce side effects and improve treatment outcomes. Additional research would then be needed. The investigators also want to investigate whether these daily measurements are feasible for patients undergoing treatment. Participation in the study involves measuring daily physical activity from the week before treatment until the first 3 months of treatment have been completed. This is done by tracking daily steps with patients own phone using the OncoSTAPP application.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Physical activity
Timeframe: From enrollment to the end of observation period (90 days on systemic treatment)
Number of patients with a hospitalization
Timeframe: From enrollment to the end of observation period (90 days on systemic treatment)
Number of patients with a treatment discontinuation
Timeframe: From enrollment to the end of observation period (90 days on systemic treatment)
Number of patients with a RDI <70%
Timeframe: From enrollment to the end of observation period (90 days on systemic treatment)
Rate of mortality
Timeframe: From enrollment to the end of observation period (90 days on systemic treatment)
Relative dose intensity (RDI) of systemic treatment
Timeframe: From enrollment to the end of observation period (90 days on systemic treatment)